BASELINE LEUKOCYTE COUNT AND ACUTE CORONARY SYNDROME: PREDICTOR OF ADVERSE CARDIAC EVENTS, LONG AND SHORT TERM MORTALITY AND ASSOCIATION WITH TRADITIONAL RISK FACTORS, CARDIAC BIOMARKERS AND CREACTIVE PROTEIN
Abstract
Background: The elevated WBC count has been accepted as part of healing response followingmyocardial infarction as well as a predictor of adverse cardiovascular events. The study was designedto find out correlation between WBC count and coronary risk factors, cardiac biomarkers, C-reactiveprotein (CRP), incidence of adverse cardiac events and mortality in patients of ACS in Pakistan.Methods: One hundred and thirty-three patients of ACS were stratified according to WBC categories,WBC1 (<7000/mm3), WBC2 (7100–10,000/mm3) and WBC3 (>10,000/mm3). The WBCs werecounted on admission by Sysmex cell counter, CRP by immunoturbidimetric method, and CK-MB andTrop-I by enzyme immunoassay. Adverse cardiac events and mortality were recorded for 12 months offollow up period. Results: Long term mortality in patients with ACS was 6.4% in WBC1, 18.2% inWBC2 and 40.9% in WBC3 categories, while short term mortality was 2.6%, 3.0% and 18.2% inWBC1, WBC2, and WBC3 categories respectively. Relative to patients in lower 2 WBC categories,patients in the highest category were 7 times more likely to die during 30 days (HR 7.83, p=0.017) andmore than 9 times during the total follow up period (HR 9.42, p<0.001). Cox regression analysisshowed WBC3 a strong independent predictor of mortality (HR 6.36, p=0.016). WBC count showed apositive correlation with coronary risk factors, cardiac biomarkers and CRP. Conclusion: WBC countis a strong independent predictor of mortality in patients with ACS and has positive correlation withcoronary risk factors, cardiac biomarkers and CRP.Keywords: Acute coronary syndrome, WBCs, Mortality, C-reactive proteinReferences
Haim M, Boyko V, Goldbourt U, Battler A, Behar S.
Predictive value of elevated white cell count in patients with
preexisting coronary heart disease. Arch Intern Med
;164:433–9.
Natalie K, Wolfgang K. Biomarkers of outcome from
cardiovascular disease. Curr Opin Crit Care 2006;12:412–9.
Grzybowski M, Welch RD, Parson L, Ndumele CE, Chen E,
Zalenski R, et al. The association between white blood cell
count and acute myocardial infarction in hospital mortality:
finding from the National Registry of myocardial infarction.
Acad Emerg Med 2004;11:1049–60.
Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte
count and coronary heart disease implications for risk
assessment. J Am Coll Cardiol 2004:44;1945–56.
Nunez J, Nunez E, Sanchis J, Bodi V, Llacer A. Prognostic
value of leukocytosis in acute coronary syndrome: the
Cinderella of the inflammatory markers. Curr Med Chem
;13:2113–8.
Laurie GF, Lamberg L. The leukocyte count, a measure and
predictor of coronary events. Am J Crit Care 2007;16:401–4.
Myocardial infarction redefined. A consensus document of
the joint European Society of Cardiology / American College
of Cardiology Committee for the redefinition of myocardial
infarction. Eur Heart J 2000;21:1502–13.
Haines AP, Howarth D, North WR, Goldenberg E, Stirling
Y, Meade TW, et al. Haemostatic variables and the outcome
of myocardial infarction. Thromb Haemost 1985;50:800–3.
Cannon CP, McCabe CH, Wilcox RG, Bentely JH,
Braunwald E. Association of white blood cell count with
increase mortality in acute myocardial infarction and unstable
angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol
;87:636–9.
Ndrepepa G, Braun S, Lijima R, Keta D, Byrne RA, Schulz
S, et al. Total leukocyte count but not C-reactive protein
predicts one year mortality in patients with acute coronary
syndromes treated with percutaneous coronary intervention.
Clin Sci (Lond) 2009;116:651–8.
Muller C, Neumann FJ, Perruchoud AP, Buettner HJ. White
blood cell count and long term mortality after non-ST
elevation acute coronary syndrome treated with very early
revascularization. Heart 2003;89:389–92.
Hung MJ, Cherng WJ. Comparison of white cell count in
acute myocardial infarction patients with significant and
insignificant coronary artery disease. Am J Cardiol
;91:1339–42.
Morange PE, Simon C, Alessi MC, Luc G, Arveiler D,
Ferrieres J, et al. Endothelial cell markers and risk of
coronary heart disease: the prospective epidemiological study
of myocardial infarction (PRIME) study. Circulation
;109:1343–8.
Avramkis G, Papadimitraki E, Papakonstandinou D, Liakou
K, Zidianakis M, Dermitzakis A , et al. Platelets and white
cell subpopulations among patients with myocardial
infarction and unstable angina. Platelets 2007;18:16–23.
Byrne CE, Fitzgerald A, Canon CP, Fitzgerald DJ, Sheilds
DC. Elevated white cell count in acute coronary syndromes:
relationship to variants in inflammatory and thrombotic
genes. BMC Med Genet 2004;5:13.
Malika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role f noval risk factors: a clinicochemical
perspective. Angiology 2007;58:513–22.
Etrl G, Frantz S. Wound model of myocardial infarction. Am
J Physiol Heart Circ Physiol 2005;288:H981–3.
Capuano V, Lamaida N, DeMartino M, Mazzotta G.
Association between white blood cell count and risk factors
of coronary artery disease. G Ital Cardiol 1995;25:1145–52.